Effect of Gevokizumab on Interleukin-1β-Mediated Cytochrome P450 3A4 and Drug Transporter Repression in Cultured Human Hepatocytes.

about

Effect of Gevokizumab on Interleukin-1β-Mediated Cytochrome P450 3A4 and Drug Transporter Repression in Cultured Human Hepatocytes.

Item

http://www.wikidata.org/entity/Q38750643

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Effect of Gevokizumab on Inter ...... in Cultured Human Hepatocytes.

@en

type

Item

label

Effect of Gevokizumab on Inter ...... in Cultured Human Hepatocytes.

@en

prefLabel

Effect of Gevokizumab on Inter ...... in Cultured Human Hepatocytes.

@en

P1476

Effect of Gevokizumab on Inter ...... in Cultured Human Hepatocytes.

@en

P2093

Amélie Moreau

http://www.w3.org/2001/XMLSchema#string

Claire Denizot

http://www.w3.org/2001/XMLSchema#string

Elodie Jouan

http://www.w3.org/2001/XMLSchema#string

Marc Le Vée

http://www.w3.org/2001/XMLSchema#string

Olivier Fardel

http://www.w3.org/2001/XMLSchema#string

Yannick Parmentier

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-1 Family Cytokines in Liver Diseases

Regulation of MRP2/ABCC2 and BSEP/ABCB11 expression in sandwich cultured human and rat hepatocytes exposed to inflammatory cytokines TNF-{alpha}, IL-6, and IL-1{beta}

Inhibition of Human Drug Transporter Activities by the Pyrethroid Pesticides Allethrin and Tetramethrin.

IL-1β is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease.

Kinetic approach to pathway attenuation using XOMA 052, a regulatory therapeutic antibody that modulates interleukin-1beta activity.

A clinical therapeutic protein drug-drug interaction study: coadministration of denosumab and midazolam in postmenopausal women with osteoporosis.

Inhibition of oat3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid.

Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics

Immunological response as a source to variability in drug metabolism and transport.

Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes

P2888

s13318-017-0406-1

P31

scholarly article

P356

10.1007/S13318-017-0406-1

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084036917

http://www.w3.org/2001/XMLSchema#string

P698

28260174

http://www.w3.org/2001/XMLSchema#string